Merck Shares Plunge on Vioxx Denial News
20275
Shares of Merck &amp; Co. plunged more than 7 percent Monday after a media report said that documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx cause heart problems.
288701
Shares of Merck plunged nearly 27 percent yesterday on news that the pharmaceutical giant was pulling the popular arthritis pain medication Vioxx off the market in the largest drug withdrawal in US history.
530890
U.S. blue chips were lower on Thursday  after drug company and Dow component Merck & Co.MRK.N said it  was withdrawing a key drug, casting a dark mood over the market  as oil prices remained above $49 a barrel.
539996
U.S. stocks ended lower on Friday,  dragged down by a sharp fall in drugmaker Merck & Co. Inc.  MRK.N on concerns about a key drug, worries ahead of the Iraq  election and weaker-than-expected economic growth.
350800
NEW YORK, Nov. 11 -- The 40 percent share price slide in Merck &#38; Co. in the five weeks after it pulled the painkiller Vioxx off the market highlighted larger problems in the pharmaceutical industry that may depress performance for years, according to academics and stock analysts who follow the sector.
347652
Pharmaceutical giant Merck & Co. said Tuesday its fourth-quarter profit plunged 21 percent, mainly due to lost sales and a big reserve taken for legal defense costs over the withdrawal of its former blockbuster arthritis drug Vioxx.
315772
Merck (MRK:NYSE - news - research) shares fell early Thursday after a study sponsored by the Food and Drug Administration concluded that its Vioxx arthritis drug put users at a greater risk to heart attacks than Pfizer&#39;s (PFE:NYSE - news - research
233794
Merck & Co Inc. Thursday pulled its  arthritis drug Vioxx off the market because it increases the  risk of heart attack and stroke, a move that sent its shares  plunging, erasing $25 billion of its market value.
394034
Merck reported that fourth-quarter profit plunged 58 percent despite higher revenue as the company took charges for revamping costs, an acquisition and legal reserves.
336558
Merck & Co Inc. MRK.N pulled its  arthritis drug Vioxx off the market on Thursday after a study  showed it doubled the risk of heart attack and stroke. The move  sent the company's shares plunging almost 27 percent and erased  $25 billion of its market value.
349051
Shares of drugmaker Merck & Co. Inc.  traded 1.52 percent higher on volume of more than 61,000 shares in pre-market dealings on Friday, a day after the stock plunged to an eight-year low after the company withdrew its arthritis drug Vioxx.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
291603
NEW YORK - Investors sent stocks lower Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
380561
Shares of Merck &amp; Co. plunged almost 10 percent yesterday after a media report said that documents show the pharmaceutical giant hid or denied
310914
NEW YORK, December 8  - Merck &amp; Co (MRK.NYS) has guided to lower-than-expected 2005 earnings due to the withdrawal of its blockbuster arthritis drug, Vioxx, and increased generic competition for its cholesterol drug, Zocor.
406135
US stock futures pointed to a slightly lower open on Tuesday as investors take a step back after last week&#39;s three-day rally, with shares of drug maker Merck &amp; Co.
673213
BOSTON (CBS.MW) -- Merck &amp; Co. shares fell more than 10 percent Monday on a news report that the company may have known for years that Vioxx, the pain reliever it recently withdrew from the market, could cause cardiac problems in some patients.